Loading
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • Pinterest
  • Youtube
  • Mail
  • Rss
  • Log In
    • Register
Contacts us @ MediPr.org
Medical Writer Agency | 香港醫學作家 | MediPR | MediPaper Hong Kong
  • MDnews
  • About [‘mediPr]
  • Search
  • Menu Menu
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share by Mail

Non-Sponsored Content


INFECTIOUS DISEASE

在本港，人們如何感染Covid-19?

分析：Dr Siddharth Sridhar，臨床微生物及感染學專科醫生 | 翻譯：Helen YC LAW, MediPaper Medical Communications Ltd.| 更新：2020年2月20日  | In: COVID-19, Critical Care Medicine, Infectious Disease, Internal Medicine, Pneumonia, SARS-CoV2

Article Keywords

2019-nCoV, China, corona virus, COVID-19, pneumonia, WARS

English Version

在這裡，我分析了Covid-19在本港的主要傳播途徑（截至2020年2月20日）：

  1. 本港大多數Covid-19都是在家庭內傳播的。 報導中的首65宗病例中，有27宗（〜42％）是感染自家庭或社交環境中接觸的家庭成員，他們在該環境中很少佩戴口罩。
  2. 然而，有16/65（24.6％）的患者是從未知的來源受感染的，而其中一些患者隨後將病毒傳染了給他們的家人。
  3. 自2020年2月7日以來，從外地傳入的病例僅佔4/41。

為了保護您的家人，請在公共場所佩戴口罩，並應避免前往擁擠的地方和參加大型聚會。

YOU MAY ALSO LIKE

content continues below

Toxic vaccine disinformation_有關疫苗的虛假信息
11th January 2021

有關疫苗的虛假信息

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions
23rd December 2020

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Dr Siddharth Sridhar - 2019-nCoV - COVID-19 - 在本港，人們如何感染Covid-19

Newsletter

YOU MAY ALSO LIKE

Toxic vaccine disinformation_有關疫苗的虛假信息

有關疫苗的虛假信息

https://medi-paper.com/wp-content/uploads/2021/01/Toxic-vaccine-disinformation_有關疫苗的虛假信息.jpg 1024 1819 Dr Siddharth Sridhar https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Dr Siddharth Sridhar2021-01-11 18:28:422021-01-11 18:35:45有關疫苗的虛假信息
Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

https://medi-paper.com/wp-content/uploads/2020/12/Patient-Blood-Management-and-Treatment-of-iron-Deficiency-Anaemia-in-Gynaecological-Conditions.jpg 938 1500 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-12-23 17:46:262020-12-23 17:58:06Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272020-09-24 12:33:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232020-09-23 17:03:43Triple combination effective for hospital- and ventilator-acquired pneumonia
PreviousNext

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2020 Dr Sridhar Siddharth – 在本港，人們如何感染Covid-19?

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share by Mail

YOU MAY ALSO LIKE

Toxic vaccine disinformation_有關疫苗的虛假信息

有關疫苗的虛假信息

https://medi-paper.com/wp-content/uploads/2021/01/Toxic-vaccine-disinformation_有關疫苗的虛假信息.jpg 1024 1819 Dr Siddharth Sridhar https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Dr Siddharth Sridhar2021-01-11 18:28:422021-01-11 18:35:45有關疫苗的虛假信息
Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions

https://medi-paper.com/wp-content/uploads/2020/12/Patient-Blood-Management-and-Treatment-of-iron-Deficiency-Anaemia-in-Gynaecological-Conditions.jpg 938 1500 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-12-23 17:46:262020-12-23 17:58:06Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272020-09-24 12:33:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232020-09-23 17:03:43Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072020-09-24 12:37:30Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352020-08-25 15:48:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance

Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance

https://medi-paper.com/wp-content/uploads/2020/08/residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 16:18:002020-08-17 16:56:12Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132020-08-17 16:56:09Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society

Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

https://medi-paper.com/wp-content/uploads/2020/08/updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 14:41:322020-08-25 14:37:07Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society
interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV

Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV

https://medi-paper.com/wp-content/uploads/2020/08/interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:44:162020-08-19 11:39:24Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV
comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis

Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

https://medi-paper.com/wp-content/uploads/2020/08/comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis-scaled.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:02:232020-08-19 11:39:13Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis
Carboplatin plus paclitaxel to be the new standard of care for anal cancer

Carboplatin plus paclitaxel to be the new standard of care for anal cancer

https://medi-paper.com/wp-content/uploads/2020/07/Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-07-10 17:24:482020-08-11 09:52:36Carboplatin plus paclitaxel to be the new standard of care for anal cancer
Dr Sridhar Siddharth - Clinical characteristics of patients with 2019-nCoV pneumonia COVID-19 2019-nCoV WuhanOutbreak Pneumonia

Updated: Clinical characteristics of patients with COVID-19

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:23:392020-09-24 12:33:08Updated: Clinical characteristics of patients with COVID-19
Dr Siddharth Sridhar - 2019-nCoV COVID-19 in Hong Kong - the end of the beginning

COVID-19 in Hong Kong: the end of the beginning?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-1-1.jpg 760 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 13:48:352020-09-24 12:33:08COVID-19 in Hong Kong: the end of the beginning?
Dr Siddharth Sridhar - 2019-nCoV COVID-19 - How do People get Covid-19 in Hong Kong 在本港，人們如何感染Covid-19

How do people get COVID-19 in Hong Kong

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港，人們如何感染Covid-19.jpg 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:582020-09-24 12:33:08How do people get COVID-19 in Hong Kong
Dr Siddharth Sridhar - 2019-nCoV - Summary of the situation in HK 2019-nCoV在本港的概況 COVID-19 2019-nCoV WuhanOutbreak Pneumonia

2019-nCoV – Summary of the situation in HK as of Feb 6, 2020

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:582020-09-24 12:33:092019-nCoV – Summary of the situation in HK as of Feb 6, 2020
Dr Sridhar Siddharth - How infectious is novel coronavirus 2019 nCoV 新型冠狀病毒 2019-nCoV 的傳染性有多高 COVID-19 2019-nCoV WuhanOutbreak Pneumonia

How infectious is novel coronavirus (2019-nCoV)

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-03 22:33:562020-09-24 12:33:10How infectious is novel coronavirus (2019-nCoV)
Dr Siddharth Sridhar - How stable are coronaviruses in the environment? 2019-nCoV 冠狀病毒在環境中的穩定性 COVID-19 2019-nCoV WuhanOutbreak Pneumonia

2019-nCoV: how stable are coronaviruses in the environment?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:45:432020-09-24 12:33:102019-nCoV: how stable are coronaviruses in the environment?
Dr Sridhar Siddharth - Who gets severe novel coronavirus (2019-nCoV) infection COVID-19 2019-nCoV WuhanOutbreak Pneumonia

Who gets severe novel coronavirus (2019-nCoV) infection?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:45:262020-09-24 12:33:10Who gets severe novel coronavirus (2019-nCoV) infection?
Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

https://medi-paper.com/wp-content/uploads/2019/04/Can-a-novel-temporary-and-fully-resorbable-surgical-implant-improve-the-outcome-of-common-hockey-and-soccer-injuries.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2019-04-26 20:05:262019-04-26 20:12:32Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?
FDA approved lusutrombopag (Mulpleta, Shionogi Inc.) for thrombocytopenia in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. More Information.  July 31, 2018.

Lusutrombopag FDA approved for thrombocytopenia in adult chronic liver disease patients

https://medi-paper.com/wp-content/uploads/2018/08/FDA-approved-lusutrombopag-Mulpleta-Shionogi-Inc.-for-thrombocytopenia-in-adults-with-chronic-liver-disease-who-are-scheduled-to-undergo-a-medical-or-dental-procedure.-More-Information.-July-31-2018-e1537925382959.jpg 1000 1495 News Feed https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png News Feed2018-08-01 09:21:032018-08-12 16:46:52Lusutrombopag FDA approved for thrombocytopenia in adult chronic liver disease patients
PreviousNext
1 reply

Trackbacks & Pingbacks

  1. How do people get COVID-19 in Hong Kong | MediPaper says:
    21st February 2020 at 11:22 PM

    […] 中文版 […]

    Log in to Reply

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply Cancel reply

You must be logged in to post a comment.

© Copyright 2020 Dr Sridhar Siddharth – 在本港，人們如何感染Covid-19?

Tab 1Tab 2Tab 3Tab 4
© 2016-2021 MediPaper Medical Communications Ltd. | Website by [’mediPr] | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • Pinterest
  • Youtube
  • Mail
  • Rss
Capivasertib added to fulvestrant improves progression-free survival in advanced... Capivasertib added to fulvestrant improves progression-free survival in advanced breast cancer patients Dr Siddharth Sridhar - 2019-nCoV COVID-19 - How do People get Covid-19 in Hong Kong 在本港，人們如何感染Covid-19 How do people get COVID-19 in Hong Kong
Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

Accept settingsHide notification only
MediPaper Medical Communications Agency Hong Kong Blog